Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
KLA Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $242.5B | |
|---|---|---|
| Revenue (ttm) | 13.6B | |
| Net income (ttm) | 4.8B | |
| EPS (ttm) | $3.66 | |
| Shares out | 1.3B | |
| P/E (trailing) | 43.3x | |
| P/E (forward) | 31.9x | |
| Dividend | $0.92 (0.58%) | |
| Volume | 7,943,102 | |
| Beta | 1.45 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | Trend |
| Revenue | $9.21B | $10.50B | $9.81B | $12.16B | $13.58B | +10.2% |
| Gross profit | $5.62B | $6.28B | $5.88B | $7.40B | $8.32B | +10.3% |
| Operating income | $3.65B | $4.09B | $3.50B | $4.95B | $5.66B | +11.6% |
| Net income | $3.32B | $3.39B | $2.76B | $4.06B | $4.83B | +9.8% |
| EPS (diluted) | $2.19 | $2.42 | $2.03 | $3.04 | $3.66 | +13.7% |
| EBITDA | $4.01B | $4.50B | $3.90B | $5.34B | $5.76B | +9.5% |
| R&D | $1.11B | $1.30B | $1.28B | $1.36B | $1.53B | +8.5% |
| SG&A | $860.0M | $986.3M | $969.5M | $1.03B | $1.13B | +7.1% |
Recent company headlines from major financial publishers.
Better component availability supports growth while FY2026 profitability holds. Weaker annual revenue expectations or sustained margin erosion by FY2028 would disconfirm it.
Core growth and profitability must persist without a large internal capital build. Renewed shipment limits or weaker margins by FY2028 would disconfirm it.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.4% | $126 | $131 | $137 | $143 | $152 |
| 9.4% | $113 | $117 | $120 | $125 | $130 |
| 10.4% | $103 | $106 | $109 | $111 | $115 |
| 11.4% | $95.1 | $96.9 | $98.9 | $101 | $104 |
| 12.4% | $88.4 | $89.7 | $91.2 | $92.9 | $94.7 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
